Boiron SA (BOIRF)

Market Cap	387.08M -28.7%
Revenue (ttm)	566.41M -1.8%
Net Income	29.92M +35.2%
EPS	1.69 +35.2%
Shares Out	n/a
PE Ratio	18.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	31.50
Previous Close	31.90
Day's Range	31.50 - 31.50
52-Week Range	24.00 - 32.28
Beta	0.46
Analysts	n/a
Price Target	n/a
Est. Earnings	Apr 22, 2027

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices (in vitro diagnostics), dietary supplements, herbal remedies, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive l...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,623
• Stock Exchange: OTCMKTS
• Ticker Symbol: BOIRF

Financial Performance

In 2025, Boiron's revenue was 501.11 million, an increase of 2.78% compared to the previous year's 487.56 million. Earnings were 32.64 million, an increase of 187.96%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error